ExeVir Company Profile, Contacts & Intelligence

BiotechnologyBe16 employeesFounded 2020
2 contacts with email or phone data2 with email data
View verified contacts Compare competitors
Employees
16
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts
Departments
2
Mapped contact coverage

ExeVir Overview

Exevir Bio is a biotech company developing efficacious heavy chain-only antibodies to prevent and treat infectious diseases and make a difference in pandemic preparedness. The technology platform of ExeVir uses humanized camelid heavy chain-only antibody fragments (VHH) fused to a human IgG Fc to create new therapeutic compounds. ExeVir is building a strong pipeline of antibody therapies with an initial focus on COVID-19 and dengue. Compared to conventional monoclonal antibodies, the modular VHH building blocks provide a unique combinatory flexibility. In addition, the design of multi-specific constructs is substantially simplified. VHHs have the potential to access unique and occluded epitopes that are often highly conserved and more difficult, if not impossible, to access for conventional monoclonals. ExeVir has gained extensive experience in the discovery, development and production of mono-specific and multi-specific VHH-Fc constructs, which are very stable, easy to produce and cost-effective. Our lead compound XVR013m is a variant-proof and broad –spectrum long-acting antibody targeting a highly conserved epitope in the S2 subunit of the Spike to protect and treat immunocompromised and elderly. The company is backed up by series A financing and has obtained non-dilutive funding from VLAIO and Horizon. The company was created in 2020 and has its headquarters in Ghent, Belgium.

Headquarters
Be
Website
exevir.com
Industry
Biotechnology
Founded
2020
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
Engineer jobs

ExeVir Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data in the visible sample.
2 departments represented
Visible contacts with email or phone data are mapped to these departments.
2 company-domain emails
Visible contacts using ExeVir's company email domain.
General
2
Healthcare
1

ExeVir People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

V
Viki Bockstal
Chief Scientific Officer Bij Exevir
F
Fiona Du Monceau - De Hemptinne
K
Katja Rosenkranz
E
K
Kenneth Bonheure
Senior Partner Emeritus at Mckinsey
E

ExeVir Workforce Composition

Seniority breakdown across 7 visible profiles.

Senior / Lead
2
Associate / junior
2
Executive
1
VP / Head
1
Individual contributor
1

ExeVir Technology & Talent

Technology-related job titles represented in the visible people data.

Data / AI
1
Engineering
1

Compare Similar Companies to ExeVir

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Argenx Biotechnology Research 1.90K View company
Galapagos Biotechnology Research 967 View company
Ablynx Biotechnology Research 125 View company
Etherna Biotechnology 103 View company
Confo Therapeutics Biotechnology 77 View company
Biotalys Biotechnology Research 70 View company
Agomab Biotechnology Research 68 View company
Ziphius Biotechnology Research 59 View company
Rewind Therapeutics Biotechnology Research 19 View company
Flamingo Therapeutics Biotechnology Research 18 View company